Albanian physician Edvin Prifti has announced that a medical item he calls “Spike Protect” has obtained regulatory approval for the European market. In a social media post, Prifti shared documentation, which he asserts confirms the authorization status of the medical product. He stated that the treatment is anticipated to be available for sale within several weeks.
According to Dr. Prifti, “Spike Protect” is described as a biological mycelium developed by himself. Its purported function is the neutralization of the Spike protein.
The protein, according to the doctor, is generated both by the SARS-CoV-2 virus and by the vaccines designed for COVID-19. Prifti stated that the European Community’s approval for the treatment marks the culmination of years of research. The announcement suggests that the product is intended to address the Spike protein mechanism within the body.
The details provided by Prifti indicate that the regulatory clearance positions the treatment for inclusion in the European healthcare market. The documentation released by the doctor purports to substantiate the claims regarding its efficacy and authorized status within the European Union framework.
Topics: #product #approval #market
